Perimeter Medical Imaging AI Announces its Participation in Multiple Upcoming Industry Conferences and Events

Download as PDF

TORONTO & DALLAS--(BUSINESS WIRE)-- Perimeter Medical Imaging AI, Inc. (TSX-V:PINK) (OTC:PYNKF) (FSE:4PC) (“Perimeter” or the “Company”), a medical technology company driven to transform cancer surgery with ultra-high-resolution, real-time, advanced imaging tools to address high unmet medical needs, announced today that it will participate in the following upcoming industry events and conferences:

  • SSO 2022 - Society of Surgical Oncology’s International Conference on Surgical Cancer Care in Dallas, TX from March 9-12, 2022.
    • Spotlight Presentation: “A New Paradigm for Intraoperative Margin Visualization with OCT + Future AI” on Friday, March 11, 2022 at 12-12:15 pm CT by Dr. Beth Dupree and Dr. Amelia Tower. Learn more.
  • NCoBC 2022 - National Consortium of Breast Centers’ 31st Interdisciplinary Breast Center Conference in Las Vegas, NV from March 11-16, 2022. Learn more.
  • ASBrS 2022 - 23rd Annual Meeting of the American Society of Breast Surgeons in Las Vegas, NV from April 6-10, 2022.
    • Breakfast Symposium: “OCT + Future AI: Changing the Paradigm for Intraoperative Margin Visualization” on Friday, April 8, 2022 from 6:15-7:45 am PT by Dr. Richard Fine (Moderator), Dr. Amelia Tower, and Dr. Maryam Elmi. Learn more.

The above listed dates and times are subject to change. Details on company presentations and webcasts can be found on the “Investors” section of Perimeter’s website at https://ir.perimetermed.com/. When available, webcasts will be posted for replay following the event.

About Perimeter Medical Imaging AI, Inc.

Based in Toronto, Canada and Dallas, Texas, Perimeter Medical Imaging AI (TSX-V:PINK) (OTC:PYNKF) (FSE:4PC) is a medical technology company driven to transform cancer surgery with ultra-high-resolution, real-time, advanced imaging tools to address areas of high unmet medical need. Available across the U.S., our FDA-cleared Perimeter S-Series OCT system provides real-time, cross-sectional visualization of excised tissues at the cellular level. The breakthrough-device-designated, investigational Perimeter B-Series OCT with ImgAssist AI represents our next-generation artificial intelligence technology that is currently under clinical development. The company’s ticker symbol “PINK” refers to the pink ribbons used during Breast Cancer Awareness Month.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Shushu Feng
Perimeter Medical Imaging AI, Inc.
Direct: 647-339-7465 (PINK)
Toll-free: 888-988-7465 (PINK)
investors@perimetermed.com

Source: Perimeter Medical Imaging AI, Inc.

Released March 10, 2022